4.3 Article

MRI characteristics of familial and sporadic multiple sclerosis patients

期刊

MULTIPLE SCLEROSIS JOURNAL
卷 19, 期 9, 页码 1145-1152

出版社

SAGE PUBLICATIONS LTD
DOI: 10.1177/1352458512469697

关键词

Multiple sclerosis; familial; sporadic; MRI; lesion burden; brain atrophy; magnetization transfer imaging; diffusion-weighted imaging; degree of affected relative

资金

  1. Biogen Idec
  2. Teva Pharmaceuticals
  3. EMD Serono
  4. Pfizer
  5. Novartis
  6. Acorda
  7. Cyberonics
  8. Allergan
  9. Netezza
  10. National Multiple Sclerosis Society
  11. Department of Defense
  12. Jog for the Jake Foundation
  13. National Institutes of Health
  14. National Science Foundation
  15. Teva Pharmaceutical Industries Ltd
  16. Pfizer Inc.
  17. Sanofi-Genzyme
  18. Bracco
  19. Questcor Pharmaceuticals

向作者/读者索取更多资源

Purpose: To investigate the MRI characteristics in a large cohort of multiple sclerosis (MS) patients with and without a family history of MS. Methods: Enrolled in this prospective study were 758 consecutive MS patients (mean age 46.2 10.1 years, disease duration 13.6 9.2 years and EDSS 3.4 +/- 2.1), of whom 477 had relapsing-remitting, 222 secondary-progressive, and 30 primary-progressive disease courses and 29 had clinically isolated syndrome. One hundred and ninety-six patients (25.9%) had a positive family history of MS. Patients were assessed using measurements of lesions, brain atrophy, magnetization transfer ratio (MTR) and diffusion-weighted imaging. Results: The familial MS group had greater T1-lesion volume (p=0.009) and a trend for lower MTR of T1-lesion volume (p=0.047) than the sporadic MS group. No clinical differences were found between familial versus sporadic group, or by a degree of affected relative subgroups. Conclusions: While familial MS was associated with more severe T1-lesion volume and its MTR characteristics, there were no clinical status differences between familial and sporadic MS patients. Therefore, a better understanding of the genetic and/or epigenetic influences causing these differences can advance the understanding and management of MS.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据